{{Infobox Officeholder
|name              = 陳建同<br>Chen Jiann-Thorng
|image             = 
|caption           = 
|imagesize         = 
|性別     = 男
|出生日期 = 1962年
|出生地點 = {{ROC}}[[台灣省|台灣省]][[花蓮縣|花蓮縣]][[花蓮市|花蓮市]]
|逝世日期 = 
|逝世地點 = 
|居處     = 
|安葬地點 = 
|籍貫     = 
|職業     = 軍人
|父母     = 
|配偶     = 
|子女     = 
|親屬     = 
|國籍     = {{ROC}}
|信仰     = 
|學歷     = [[美國|美國]][[紐約州立大學|紐約州立大學]][[哲學|哲學]][[博士|博士]]
|別名     = 
|allegiance = {{ROC}}
|branch = {{flagicon image|Flag of the Republic of China Army.svg}} [[中華民國陸軍|中華民國陸軍]]
|rank = {{flagicon image|ROCA_Lieutenant_General's_Flag.svg}} [[中將|中將]]
}}
'''陳建同'''（Chen Jiann-Thorng）（1962年－），[[中華民國陸軍|中華民國陸軍]][[中將|中將]]，生於[[台灣省|台灣省]][[花蓮縣|花蓮縣]][[花蓮市|花蓮市]]<ref>[http://www.ndmctsgh.edu.tw/editor_model/u_editor_v1.asp?id=%7BAE81BAC9-65A4-49A3-A943-2287EB63E96B%7D 陳建同博士網頁]</ref>，現任[[國防部軍醫局|國防部軍醫局]]局長，曾任[[國防部軍醫局|國防部軍醫局]]少將副局長、[[國防醫學院|國防醫學院]]上校教學副院長、醫學系主任、[[陸軍後勤指揮部|陸軍後勤指揮部]]軍醫處長，畢業於[[花崗國中|花崗國中]]、[[花蓮高中|花蓮高中]]、[[國防醫學院|國防醫學院]]醫學系、獲得[[美國|美國]][[紐約州立大學|紐約州立大學]][[哲學|哲學]][[博士|博士]]。三軍總醫院眼科部主治醫師。 中華民國眼科協會理監事<ref>[http://www.oph.org.tw/?action=news_content&cid=11 中華民國眼科醫學會]</ref><ref>[http://www.ndmctsgh.edu.tw/editor_model/u_editor_v1.asp?id=%7BAE81BAC9-65A4-49A3-A943-2287EB63E96B%7D 陳建同博士網頁]</ref> <ref>[http://www.tsgh.ndmctsgh.edu.tw/serverdoctor/doctorpage_3.asp?ED=OPH 三總眼科網頁]</ref>。學術專長：[[分子生物學|分子生物學]]，[[細胞學|細胞學]]，[[病理學|病理學]]，[[眼科|眼科]]。<ref>[http://wegenius.org/node/197 什麼是黃斑部病變?]</ref>

1998年，陳建同以論文''{{Cite journal|title =[http://catalog.lib.buffalo.edu/vufind/Record/001943901 The Nature of the resistance to steroid hypertension in Wistar-Furth rats]''}}獲得[[紐約州立大學水牛城分校|紐約州立大學水牛城分校]]博士學位；指導教授是Dr.Samuel Gallant博士。<ref>[http://medicine.buffalo.edu/faculty/profile.html?ubit=gallant Associate Professor,Samuel Gallant]</ref><ref>[http://books.google.com.tw/books/about/The_Nature_of_the_Resistance_to_Steroid.html?id=9oouOAAACAAJ&redir_esc=y Reference英文參考資料]</ref><ref>[http://catalog.lib.buffalo.edu/vufind/Record/001719112 參考文獻 Resistance of the Wistar/Furth rat to steroid-induced hypertension - response to mineralocorticoids and glucocorticoids] Kayes, Kathleen M.1995 </ref><ref>[http://catalog.lib.buffalo.edu/vufind/Record/001851724 參考文獻 Studies of steroid-induced hypertension in wistar and wistar/furth rats] Yu, Cheng-Ping 1997 </ref><ref>[http://catalog.lib.buffalo.edu/vufind/Record/000769346 參考文獻Resistance of the Wistar-Furth rat to mineralocorticoid-induced hypertensive cardiovascular disease 1989]</ref>

==家庭與生平==
生於[[花蓮縣|花蓮縣]][[花蓮市|花蓮市]]，51年次（1962年生），家中長子，父親陳坤桓是花蓮市忠孝國小退休校長、母親翁淑子則是中正國小退休老師。陳建同畢業於明義國小、花崗國中、花蓮高中。<ref>[http://www.ksnews.com.tw/index.php/news/detail/0000565477 花蓮子弟出將官 陳建同升少將]</ref>

==醫療糾紛==
因醫療糾紛，墮胎併發眼疾致失明，經法院判決，認定診治醫師陳建同在病情發生變化時，未重新檢查追查原因，延誤治療，改判三總及陳建同醫師判賠244 萬。經查證後，陳建同先生博士論文為內科高血壓之研究，非眼科，專業判斷受到質疑而導致醫療疏失。

==博士論文爭議==
陳建同博士所發表的論文，與Dr. Yu, Cheng-Ping之相似度高達百分之60，有學術剽竊plagiarism之可能性。由於近年來國軍高階將官論文抄襲事件層出不窮，前國防部長楊念祖閃辭，震驚全國，也啟動教育部對於高階將官博士論文之審查。<ref>[http://catalog.lib.buffalo.edu/vufind/Record/001851724 參考文獻 Studies of steroid-induced hypertension in wistar and wistar/furth rats] Yu, Cheng-Ping 1997 </ref> <ref>http://www.libertytimes.com.tw/2013/new/aug/7/today-t1.htm 學術剽竊</ref>[http://books.google.com.tw/books/about/The_Nature_of_the_Resistance_to_Steroid.html?id=9oouOAAACAAJ&redir_esc=y 陳建同博士論文。] 但反方辯護，陳建同博士1998年發表的博士論文，只有在結構和實驗設計上與Dr. Yu 於1997年所發表的博士論文，有部分雷同之處，並無學術剽竊的事實。因為在撰寫論文時，結構體上過於相似，造成誤解。雙方論點，仍然需第三方學術單位公證。因此，有關論文爭議事件，完全屬於假設，並非事實。

陳建同博士於1998年，發表的博士論文，題目如下:

"The Nature of the Resistance to Steroid Hypertension in Wistar Furth Rats"

於1997年，Dr. Yu 所發表的博士論文，題目如下:

"Studies of Steroid-induced Hypertension in Wistar and Wistar/Furth Rats" 

經過文本分析，內容相似度頗高，且實驗方法與設計，幾乎相同；英文的用字也非常雷同；由於發表的年分接近，學術剽竊的疑慮仍然存在，目前尚待查正並釐清。

==論文摘要分析==
第三方，對於兩位學者的論文摘要進行比對分析，結果如下。

Dr. Yu, 1997, Studies of Steroid-induced Hypertension in Wistar and Wistar/Furth Rats 論文摘要:
{{cquote| Abstract
The mechanism of resistanec of the Wsitar/Furth(W/fu) rat to both mineralocorticoid and glucocorticoid hypertension was investigated. Sodium handling by W/Fu rats is different  from that by Wistar rats. Saline alone has a positive effect on blood pressure in Wistar, but no in W/Fu, rats. Mineralocorticoid treatment can induce saline polydipsia in both strains, but it is more severe in Wistar than in W/Fu rats. Also, hypermatremia develops in mineralocorticoid treated Wistar, but not in W/Fu, rats. These data indicate that, under conditions of sodium loading, W/Fu rats retain less sodium than Wistar rats do. The effects of mineralocorticoids on gene expressio of Na, K-ATPase, sodium channel, mineralocorticoid receptor, and glucocorticoid receptor are also different between these two strains. The data from our studies indicate that this lower sodium retention plays an important role in the resistance of W/Fu rats to mineralocorticoid hypertension, and that the basic mechanism for this resistance may involve a genetic difference in the susceptibility to salt between two strains.  }}

陳建同博士，1998年，The Nature of the Resistance to Steroid Hypertension in Wistar Furth Rats論文摘要:

{{cquote| Abstract
The Nature of the resistance of the Wistar-Furth(W/fu) rat strain to steroid hypertension was investigated.The basal levels of renal kallikrein mRNA and kallikrein activity measured in intact or uninephrectomized animals were higher in W/Fu than in WI rats. The induction of renal kallikrein mRNA in response to DOCA treatment was similar in both strains. However Renal kallikrein activity increased progressively in W/Fu rats and declined in WI rats. Both urinary total and active kallikrein activities were higher in DOCA-treated W/Fu rats than in the similar treated WI rats. 

Co-adminstration of DOCA and Hoe 140, a bradykinin type 2 receptor antagonist, raised the blood pressure of W/Fu rats into the hypertension range. Furthermore, with this regimen W/Fu rats developed hypernatremia. These findings suggest that bradykinin(a product of kallikrein action) plays an important role in the resistance of W/Fu rats to mineralocorticoid hypertension. Collectively, these results suggest that W/Fu rats have a more active renal kallikrein-kinin system.  }}

辯護方認為，雖然實驗設計方法類似，但實驗結果有差異，這本屬醫學研究上可容許範圍，雖然結構文體上有相似度，仍然不構成學術剽竊[[:抄袭|Plagiarism]]之定義上事實。因此，論文剽竊相關事件不存在。

==洪仲丘事件記者會發言==
2013年7月18日，時逢[[洪仲丘事件|洪仲丘事件]]發生，而在當日，時任[[陸軍後勤指揮部|陸軍後勤指揮部]]軍醫處處長佔[[上校|上校]]缺的陳建同被請去參與由時任[[中華民國陸軍司令|陸軍司令]][[李翔宙|李翔宙]][[上將|上將]]、[[中華民國政戰|政戰主任]][[曾有福|曾有福]][[中將|中將]]、[[陸軍六軍團|陸軍六軍團]]指揮官[[陳泉官|陳泉官]][[中將|中將]]等人親自召開與全程參與的[[國防部陸軍司令部|陸軍司令部]]記者會說明洪仲丘案相關事證。<ref>[https://www.nownews.com/news/20131225/1067553 將官晉升沒有他！洪仲丘269旅新旅長　半年沒出事再說]</ref>

==新聞事件==
*[http://www.phsea.com.tw/forum/forum.php?mod=viewthread&tid=16666 三軍總醫院副院長陳建同拜會王縣長        發布日期：2012-09]
*[https://web.archive.org/web/20160304200500/http://news.gpwb.gov.tw/news.aspx?ydn=026dTHGgTRNpmRFEgxcbfc4F8J3ahtuG7OxCtCB9AyWvn0mfoFaOVW+JGLCCH6FOYb%2F9k2i7NGVfapFro0MAEGIhLlluaGpEnUU7E3dKy8w%3D 三總永恆的生命紀念園區揭牌]
*[http://www.libertytimes.com.tw/2008/new/jan/21/today-life6.htm 醫療糾紛爭議事件]

==參考資料==
{{reflist}}

{{中華民國現役陸軍中將}}
[[Category:國防醫學院校友|Category:國防醫學院校友]]
[[Category:紐約州立大學校友|Category:紐約州立大學校友]]
[[Category:中華民國陸軍少將|Category:中華民國陸軍少將]]
[[Category:臺灣軍醫師|Category:臺灣軍醫師]]
[[Category:陳姓|Category:陳姓]]